Your Patients Need Vijoice—Here's How to Help Them Get It

As a provider managing patients with PIK3CA-Related Overgrowth Spectrum (PROS), prescribing Vijoice (Alpelisib) is only the first step. Getting the medication into your patient's hands requires navigating specialty pharmacy logistics, insurance prior authorization, and financial assistance programs—a process that can be daunting for families who have never dealt with specialty medications before.

This guide outlines practical steps you and your team can take to streamline Vijoice access for your patients.

Current Vijoice Availability

As of early 2026, Vijoice is not in shortage per FDA or ASHP databases. Novartis maintains stable manufacturing and distribution of all dosage forms (50 mg, 125 mg, and 200 mg tablets; 50 mg oral granule packets).

The access barriers patients face are systemic, not supply-related:

• Vijoice is dispensed exclusively through specialty pharmacies
• Prior authorization is required by virtually all payers
• The $31,754/month cost creates financial barriers without assistance
• Many patients and caregivers are unfamiliar with specialty pharmacy workflows

For the full picture on availability challenges, see our provider shortage briefing for 2026.

Why Patients Can't Find Vijoice on Their Own

Most patients will try to fill their prescription the way they would any other medication—by taking it to their local pharmacy. This doesn't work with Vijoice for several reasons:

• Retail pharmacies don't stock it: The combination of ultra-rare indication and $31,754 price point means no retail pharmacy carries Vijoice on hand.
• Patients don't know about specialty pharmacies: Many families have never used a specialty pharmacy and don't understand the separate enrollment, verification, and shipping process.
• Prior authorization confusion: Patients may interpret a pending or denied prior authorization as "the pharmacy doesn't have it" rather than an insurance issue.
• Time pressure: If a patient is newly diagnosed and newly prescribed, the 1-3 week setup time for specialty pharmacy + prior authorization can feel like an eternity.

5 Steps to Help Your Patients Access Vijoice

Step 1: Initiate Prior Authorization at the Time of Prescribing

Don't wait for the pharmacy to trigger the prior authorization. Submit it proactively the same day you write the prescription. Key documentation to include:

• Confirmed PIK3CA gene mutation (genetic test results)
• Clinical documentation of severe PROS manifestations
• Rationale for systemic therapy
• Board-certified specialist credentials (genetics or vascular disorders)

Many payer policies specifically require prescribing by or in consultation with a board-certified specialist in genetic or vascular disorders. Ensure this is documented clearly.

Step 2: Connect the Patient with a Specialty Pharmacy

Identify the specialty pharmacy in your patient's insurance network that handles Vijoice. Common specialty pharmacy partners include large national providers and Novartis-affiliated networks. If you're unsure which pharmacy to use, Novartis patient support (1-877-577-7756) can help identify the right one.

Send the prescription directly to the specialty pharmacy rather than having the patient present it at retail.

Step 3: Enroll in Novartis Financial Assistance Programs

At the time of prescribing, help patients connect with financial assistance:

• Commercially insured patients: Novartis Oncology Universal Co-Pay Program — patients may pay as little as $0/month with up to $15,000/year in copay coverage. Enrollment: 1-877-577-7756 or Copay.NovartisOncology.com.
• Uninsured/underinsured patients: Novartis Patient Assistance Foundation (NPAF) — free medication for eligible patients. Enrollment: 1-800-277-2254 or pap.novartis.com.

Initiating financial assistance concurrently with prior authorization prevents delays once the insurance approval comes through.

Step 4: Set Expectations with the Patient and Caregivers

Explain to families that:

• Vijoice will arrive from a specialty pharmacy, often by mail—not from a local pharmacy
• The initial setup may take 1-3 weeks for prior authorization and pharmacy enrollment
• Ongoing refills will be smoother once the process is established
• They should start refill requests at least 2 weeks before their supply runs out

Providing this context upfront reduces anxiety and prevents unnecessary calls to your office.

Step 5: Use Medfinder for Providers as a Resource

Medfinder offers a real-time tool for checking Vijoice availability across pharmacy networks. Share this resource with patients who are experiencing delays or who need to verify that a pharmacy has the medication in stock before processing their order.

Alternatives to Consider During Access Gaps

If a patient faces a significant delay in accessing Vijoice (more than 1-2 weeks), consider the following:

• Sirolimus (Rapamune): The most commonly used off-label alternative for PROS. Available as a generic with broader pharmacy access. Requires therapeutic drug monitoring.
• Supportive care: Compression therapy, physical therapy, and symptom management can help maintain patient quality of life during access gaps.
• Clinical trials: For patients who may be candidates, investigational agents like Miransertib (an AKT inhibitor) may be available through clinical trial enrollment.

For a patient-facing comparison of treatment alternatives, see alternatives to Vijoice.

Workflow Tips for Your Practice

• Create a Vijoice prescribing checklist: Include prior authorization documentation requirements, specialty pharmacy contact information, and Novartis program enrollment steps.
• Designate a point person: If possible, assign a nurse coordinator or prior authorization specialist to manage Vijoice access for your PROS patients.
• Track authorization timelines: Follow up on prior authorization submissions after 5 business days if no response has been received.
• Document everything: Keep copies of genetic test results, clinical notes supporting severity, and prior authorization correspondence in the patient record for easy access during renewals.
• Leverage Novartis Field Reimbursement Managers: These representatives can assist with prior authorization strategies and payer-specific requirements.

Final Thoughts

Getting your patients on Vijoice 50 Mg 28 Day requires more than writing a prescription—it requires navigating a specialty access ecosystem. But with proactive prior authorization, early financial assistance enrollment, clear patient communication, and the right pharmacy partner, you can minimize delays and keep your PROS patients on continuous therapy.

For the latest on Vijoice supply and prescribing considerations, see our provider shortage briefing. For a financial access guide to share with patients, see how to save money on Vijoice.

Visit Medfinder for Providers for real-time availability tools.